Edwards Lifesciences Corporation (EW) stock slips after being downgraded at Leerink Swann

Edwards Lifesciences Corporation (NYSE: EW) shares fell on Thursday February 2 on heavier trade volume than normal after a number of analysts weighed in on the investing value of the stock with a downgraded rating.

Meanwhile, The Dow Jones Industrial Average DJIA, -0.10% fell 34 points, or 0.2%, to 19,858. The S&P 500 SPX, -0.11% lost 4 points to 2,276, a drop of 0.2%. The Nasdaq Composite Index COMP, -0.05% slid 16 points, or 0.3%, to 5,626. Among the most actively traded Nasdaq stocks was Facebook Inc FB, +0.31% which fell 0.7% a day after it reported its quarterly results.

Shares of Edwards Lifesciences Corporation (NYSE: EW) were downgraded by analysts at Leerink Swann in a note to their investors today. Leerink Swann currently has a rating of Market Perform on the stock. The one-year price target of $116.24 is higher than the opening price of $92.16, causing a number of other analysts to issue statements on the company recently. Looking back over the last year, Edwards Lifesciences Corporation stock has a high of $121.75. Downgrades happen when analysts consider that the future prospects for the security have weakened from the original recommendation, usually caused by an important and crucial change in the company’s operations, future vision or industry.

Shares of Edwards Lifesciences Corporation (NYSE: EW) opened at $92.16 yesterday and traded in a range between, $86.55 and $92.19, and last traded at $88.05, which is a dip of $9.98 compared to the previous closing price.

Edwards Lifesciences Corporation (NYSE: EW) currently has a market cap of 18.83B.

Edwards Lifesciences Corporation (NYSE: EW) Average Daily Trading Volume

The stock’s average daily volume is 2,233,650 shares out of a total float 212,317,000 and some 3,200,607 shares traded hands yesterday, 54 percent above the average. higher than normal. Significant increases in trading volume and price appreciation together could signal heavy volume accumulation by institutional investors.

As with all potential breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to show that fund managers and other professional investors are jumping in.

Institutional sponsorship simply refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors retain teams of analysts that research thousands of stocks. Thus, watching their interests is a good way to make sure you are buying the right stocks.

Edwards Lifesciences Corporation (NYSE: EW) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By identifying trends, moving averages allow traders to make those trends work in their favor and increase the number of winning trades.

Trades for Edwards Lifesciences Corporation (NYSE: EW) have ranged from $75.29 – 121.750, and the stock now has a 50-day MA of $94.96 and 200-day MA of $103.95. Today’s last price is 27.68%% below the 52 week high of $121.75.

Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors identify companies that have raised their earnings at least 25% or more over the past 3 years.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply